Apo E variants in patients with type III hyperlipoproteinemia

1996 ◽  
Vol 127 (2) ◽  
pp. 273-282 ◽  
Author(s):  
Fernando Civeira ◽  
Miguel Pocoví ◽  
Ana Cenarro ◽  
Elena Casao ◽  
Elisabet Vilella ◽  
...  
2015 ◽  
Vol 5 (3) ◽  
pp. 204-212 ◽  
Author(s):  
Satoshi Takasaki ◽  
Kunihiko Maeda ◽  
Kensuke Joh ◽  
Shu Yamakage ◽  
Sachiko Fukase ◽  
...  

Lipoprotein glomerulopathy (LPG) is characterized by histopathological features showing intra-glomerular lipoprotein thrombi and type III hyperlipoproteinemia (HLP), with heterozygote mutation of apolipoprotein (apo) E gene. On the other hand, as another renal lipidosis with type III HLP, apoE2 homozygote-related glomerulopathy (apoE2-GN) showing foamy macrophages has been reported. The case of a 25-year-old man who had LPG by clinical behavior and gene analysis, but demonstrated atypical histopathological features with a substantial amount of foamy macrophage infiltration in the glomeruli, is presented. The combination of alleles for apoE Tokyo/Maebashi and classical apoE2 (Arg158Cys) was inferred to be the leading cause of the unique renal pathology with lipoprotein thrombi and foamy macrophages. In addition, foamy macrophages infiltrated some part of the apoE-positive region within the glomerulus, but did not exist in lipoprotein thrombi despite apoE positivity, suggesting that properties of apoE are crucial in the development of LPG rather than macrophage function. This case provides important information related to the pathogenesis of LPG and apoE2-GN.


1998 ◽  
Vol 44 (4) ◽  
pp. 773-778 ◽  
Author(s):  
Martin Rexin ◽  
Giso Feussner

Abstract We developed a rapid and simple competitive reverse transcription-polymerase chain reaction for the quantification of apoε mRNA in human monocyte-derived macrophages. The method was applied, and its reliability was shown in patients with the familial lipoprotein disorder, type III hyperlipoproteinemia. Type III hyperlipoproteinemic patients express markedly higher concentrations of apoε mRNA when compared with healthy controls. Patients with this disease are usually (>90%) homozygous for a receptor binding-defective isoform of apolipoprotein apo E (apo E2). The higher expression of apoε mRNA in the patients could, therefore, be a physiological mechanism to compensate for functionally defective apo E. The developed procedure might be valuable in assessment of apoε gene expression in human disease.


1989 ◽  
Vol 17 (1) ◽  
pp. 133-139 ◽  
Author(s):  
Hiroshi NAKATA ◽  
Masaaki ETO ◽  
Akizuki MORIKAWA ◽  
Kiyoshi WATANABE ◽  
Kaneo ISHII ◽  
...  

1982 ◽  
Vol 23 (8) ◽  
pp. 1224-1235
Author(s):  
J L Breslow ◽  
V I Zannis ◽  
T R SanGiacomo ◽  
J L Third ◽  
T Tracy ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document